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During a study of the nutritional requirements of clinical isolates of Escherichia coli, we found 
that 21 (7.0%) of 301 strains required nicotinamide to grow in minimal medium. The nicotin-
amide-requiring strains were present in 16 (15.8%) of 101 cultures of urine from young women 
with acute cystitis, in 5 (5.0%) of 100 stool specimens from healthy adults, and in none of 100 
blood samples from adult patients with bacteremia. Most of the strains belonged to serogroup 
OI8:KI:H7, were hemolytic, possessed type I fimbriae, and exhibited similar patterns of antibi-
otic susceptibility. Two of the urinary isolates expressed S fimbriae, and all 16 urinary isolates 
contained the s/aS homologue gene on their chromosomes. One of the stool isolates contained 
the s/aS gene. The urinary isolates closely resembled a large clone of E. coli that is reportedly 
associated with neonatal meningitis and sepsis. It may be possible to detect this and related 
clones by their requirement for nicotinamide and to screen strains for S fimbriae by relatively 
inexpensive hemagglutination methods, including the use of avian PI antigens to detect man-
nose-resistant, non-P-fimbriated E. coli; the agglutination of bovine erythrocytes; and the use of 
bovine mucin to detect sialyl galactosides in S fimbriae. 
Most strains of Escherichia coli grow in minimal media 
containing salts, trace metals, and a simple source of carbon 
and nitrogen. Naturally occurring auxotrophic variants have 
been isolated from patients with urinary tract infections, neo-
natal meningitis, and sepsis [1-7]. The most common nutri-
tional requirement is for nicotinamide [1-3], but some 
strains need cysteine, thiamine, thymidine, glutamine, 
various amino acids [4-6], or horse serum [7]. In addition, 
most naturally occurring temperature-sensitive auxotrophs 
of E. coli require nicotinamide for growth at 42°C [8, 9]. 
During a study of the nutritional and osmotic require-
ments of clinical isolates of E. coli [9-11], we isolated a 
group of strains that required nicotinamide for growth in 
minimal medium from the urine of young women with acute 
cystitis and from stools of healthy subjects. Most of these 
strains were hemolytic and belonged to serogroup 
OI8:KI:H7. This serogroup reportedly is associated with 
neonatal meningitis and sepsis [3, 12] and possesses both 
type I and S fimbriae. In this report we present evidence that 
the nicotinamide-requiring strains of E. coli 0 18:K I :H7 iso-
lated from the urine of young adults contain either fully ex-
pressed S fimbriae or the sfaS homologue gene on their chro-
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mosomes and resemble strains causing neonatal meningitis. 
This observation strongly suggests that these two groups of 
strains belong to the same clone. The requirement for nico-
tinamide may provide a useful epidemiological marker for 
this and related clones. . 
Materials and Methods 
Strains of E. coli. Urinary isolates of E. coli were ob-
tained from 101 young women with acute urinary tract infec-
tion who were seen consecutively at the Ohio State Univer-
sity Student Health Center. All urine specimens contained 
> 105 cfu of E. coli/mL. Isolates of E. coli were also obtained 
from cultures of blood from 100 patients; these isolates were 
provided by the clinical microbiology laboratories of the 
Ohio State University Hospitals and several local commu-
nity hospitals. Finally, isolates of E. coli were obtained from 
stool samples from 100 healthy young adults (male and fe-
male student volunteers) and laboratory personnel. These 
samples were collected by rectal swab, diluted in I mL of 
phosphate-buffered saline (PBS, pH 7.2), and inoculated 
onto MacConkey agar plates. After overnight growth stock 
cultures obtained from a single colony of each isolate were 
stored at -40°C in Schaedler's broth containing 15% glyc-
erin (Difco, Detroit). 
Media and chemicals. Minimal medium was composed 
of glucose (2.0 glL), dipotassium phosphate (10.5 glL), 
monopotassium phosphate (4.5 glL), sodium citrate (0.5 
glL), magnesium sulfate (0.264 glL), and ammonium sulfate 
(1.0 glL) [13]. The pH of the medium was adjusted to 7.2 
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before use; the osmolarity was 238 mOsm/kg. In some exper-
iments minimal medium was supplemented with 0. 1-1 .0 M 
NaCl, or minimal essential medium containing nonessential 
amino acids (20 mL/L), or minimal essential medium con-
taining essential amino acids (40 mL/L) or individual amino 
acids, nicotinic acid, nicotinamide, quinolinic acid, trigonel-
line, and NI methylnicotinamide (Sigma Chemical, St. 
Louis). Chicken eggs were purchased from a local store. 
Cockatiel and pigeon eggs were obtained from local 
breeders. Other media used included trypticase soy broth, 
trypticase soy agar, brain-heart infusion broth (BBL, Cock-
eysville, MD), and CFA agar (composed primarily of casa-
mino acids and yeast extract) [14]. 
Growth conditions. A single colony was isolated on Mac-
Con key agar plates and grown overnight at 37°C in minimal 
medium broth. The inoculum, consisting of a I :20 dilution 
of a 0.5 McFarland standard (final concentration, - 5 X 105 
cfu/mL), was added to tubes containing 0.9 mL of minimal 
medium. The tubes were incubated at 37°C and 42°C for 48 
hours. Optical density was determined at 600 nm with a 
Spectronic 601 spectrophotometer (Milton Roy, Roches-
ter, NY). 
Serological typing. One hundred of the strains were char-
acterized by 0, H, and K I antigens and by hemolysin produc-
tion at the Central Public Health Laboratory of the Ontario 
Ministry of Health in Toronto. 
Identification of type I, P, and S fimbriae. For the identi-
fication of type I man nose-sensitive fimbriae, E. coli was 
grown in brain-heart infusion broth for 48 hours at 37°C. 
The cells were harvested by centrifugation, washed twice, 
and prepared as a suspension containing - 5 X 1010 cfu/mL. 
Guinea pig blood was collected in heparinized tubes. The 
erythrocytes were washed twice in PBS and resuspended at a 
3% concentration. Hemagglutination was measured at room 
temperature by gentle mixing for 5 minutes on a glazed 
white ceramic tile in the presence or absence of an equal 
volume of 3% o-mannose. 
For the identification of P fimbriae, E. coli was grown 
overnight at 3rC on CFA agar plates. The cells were 
scraped from the surface of the plates, washed twice in PBS, 
and prepared as a suspension containing -5 X 1010 cfu/mL. 
Human 0 erythrocytes were prepared from blood collected 
in heparinized tubes. The cells were washed three times in 
PBS and resuspended at a final concentration of 5%. Hemag-
glutination was evaluated on glass slides rotated at 60 revolu-
tions per minute over ice, with or without an equal volume of 
5% a-methyl-o-mannoside or other inhibitors. The presence 
of man nose-resistant P fimbriae was confirmed by use of la-
tex particles on which a-o-Gal( -4 )-,B-o-Gal-disaccharide 
was covalently bonded (PF test, Orion Diagnostica, Espoo, 
Finland) [15]. 
Mannose-resistant E. coli was considered to lack P fim-
briae if the PF test with digalactoside-coated latex beads gave 
negative results and if hemagglutination was blocked by pi-
geon and cockatiel (but not chicken) egg white [16]. Each 
experiment included the following controls: (I) boiling of 
the strain for 5 minutes to destroy fimbrial proteins; (2) test-
ing of a strain of E. coli 027:H31 that contained type I fim-
briae only; and (3) testing of a mannose-resistant strain of E. 
coli 02:H7 that possessed P fimbriae detected by the PF test. 
Evidence that the strains possessed S fimbriae was based 
on the ability of fetuin and bovine submaxillary mucin 
(Sigma Chemical) to block mannose-resistant hemagglutina-
tion. The presence ofS fimbriae was confirmed by hemagglu-
tination of bovine erythrocytes with and without 2% man-
nose [17] and by whole-cell ELISA [18] employing a 
monoclonal antibody (mAb A I) specific for the S adhesin 
SfaS obtained by K. Jann Freiburg [19]. A DNA probe spe-
cific for the gene sfaS, which codes for the sialic acid-specific 
adhesin, was generated by polymerase chain reaction with a 
suitable oligonucleotide primer pair on the basis of the nu-
cleotide sequences of sfaS. The DNA probe was labeled with 
32p by means of the random priming system [20] (Boehringer 
Mannheim, Germany). Colony dot hybridization was under-
taken as described previously [21]. E. coli strains 536 
(06:KI5) and IHE3034 (018:KI) as well as the clone 
HB I 0 I /pANN80 1-13 carrying the cloned sfa determinant 
were used as controls. 
Antimicrobial susceptibility testing and identification of 
species. Tests of antimicrobial susceptibility and species 
identification were performed in standardized microwell di-
lution plates prepared by the Clinical Microbiology Labora-
tory of the Ohio State University. The panel contained 16 
antimicrobial drugs, including aminoglycosides; ampicillin, 
amoxicillin, and ticarcillin with and without c1avulanate or 
sulbactam; mezlocillin; cefazolin; ceftizoxime; ceftazidime; 
imipenem; nitrofurantoin; and trimethoprim-sulfamethoxa-
zole. 
Analysis of data. The data were entered into the Epi Info 
program, Version 5 (Centers for Disease Control, Atlanta), 
and were analyzed by the X2 test [22]. 
Results 
Isolation of nicotinamide-requiring strains of E. coli. The 
30 I isolates obtained from blood, urine, and stool were 
tested for their ability to grow at 37°C in minimal medium 
with and without added 0.1 M increments of NaCl. Isolates 
that failed to grow were retested in medium containing 
amino acid mixtures, yeast extract, thiamine, or nicotin-
amide. Twenty-one (7.0%) of the clinical isolates failed to 
grow in minimal medium, even with added NaCI, unless 0.1 
mM nicotinic acid or nicotinamide was added. These isolates 
were quite distinct from osmo-remedial variants of E. coli 
that require nicotinamide to grow in hypotonic medium [10]. 
Nicotinamide-requiring strains of E. coli were isolated 
from 16 (15.8%) of the 101 urine samples from women with 
acute cystitis and from five (5.0%) of the 100 stool specimens 
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Table 1. Compounds that supported the growth in minimal me-
dium of nicotinamide-requiring strains of E. coli 0 18:K I :H7. 
Compound 
Nicotinamide 
Nicotinic acid 
N' methylnicotinamide 
Quinolinic acid 
Trigonelline 
Minimal concentration (M) 
supporting growth 
10-7 
10-6 
10-' 
10-3 
10-3 
NOTE. Aspartic acid. glutamic acid. glutamine, and oxalacetic acid 
(10- 3 M) failed to support the growth of these strains in minimal medium. 
from healthy adults (P < .000 I). No such isolates were recov-
ered from the 100 blood samples tested. All of 15 nicotin-
amide-requiring strains tested were found to be hemolytic 
and to belong to serogroup 0 18:K I :H7. These 15 isolates 
were uniformly susceptible to several ,B-Iactam antibiotics, 
aminoglycosides, tetracycline, nitrofurantoin, and ciproflox-
acin. 
The intermediate metabolites of nicotinamide that sup-
ported the growth of these strains are shown in table I. Nico-
tinamide was the most active; next were nicotinic acid, NI 
methylnicotinamide, quinolinic acid, and trigonelline. 
Characterization of fimbriae of nicotinamide-requiring 
strains. That all nicotinamide-requiring strains of E. coli 
o 18:K I :H7 contained type I fimbriae was shown by man-
nose-sensitive agglutination of guinea pig erythrocytes. The 
lack ofP fimbriae in these strains was documented with diga-
lactoside-coated beads. Twelve (75%) of the 16 urinary iso-
lates and 2 of the 5 stool isolates exhibited mannose-resistant 
hemagglutination of human 0 erythrocytes. Hemagglutina-
tion was not blocked by a 1:8 dilution of cockatiel or pigeon 
egg white, which is known to contain PI antigens [16]. In 
contrast, hemagglutination of P-fimbriated strains of E. coli 
02:H7 was completely blocked by I :32 and I :64 dilutions of 
cockatiel and pigeon egg white, respectively, but not by un-
diluted chicken egg white. Bovine submaxillary mucin con-
taining a final concentration of 1.1 mM free N-acetylneura-
minic acid (NANA) and fetuin containing 1.6 mM free 
NANA blocked hemagglutination of four representative 
strains in the presence of 2.5% a-methyl-o-mannoside. 
These studies provided preliminary evidence that the strains 
possessed S fimbriae based on the finding of non-P, man-
nose-resistant adhesins that were blocked by sialyl galacto-
sides [15, 23]. 
To confirm the presence of S fimbriae or their chromo-
somal gene, all of the strains were examined for their ability 
to agglutinate bovine erythrocytes; an ELISA with S fimbria-
specific monoclonal antibodies and hybridization with an 
sfaS gene probe were used. Two of the urinary isolates pos-
sessed S fimbriae detectable by both agglutination of bovine 
erythrocytes and ELISA. All 16 urinary isolates contained 
the sfaS gene. None of the five stool isolates expressed S 
fimbriae, and only one contained the sfaS gene. 
Other clinical isolates and auxotrophic strains. Several 
other strains of E. coli 018 that did not require nicotinamide 
for growth were isolated. These strains were of serogroups 
o 18:H I (four strains) and 0 18:NM (one strain). They pos-
sessed neither the KI antigen nor P fimbriae and were not 
hemolytic. 
Twelve (4.0%) of the 30 I clinical isolates (serogroups 
027:K I :H31 and 02:H7) were osmo-remedial; that is, they 
failed to grow in minimal medium unless the osmolality was 
raised by addition of NaCI, sucrose or mannitol, or nicotin-
amide. These strains are characterized in a separate report 
[10]. The nutritional requirement of one additional strain 
could not be determined. This was a blood isolate of E. coli 
01 :H4 that grew only in trypticase soy broth or in I % yeast 
extract broth; it was resistant to trimethoprim-sulfamethoxa-
zole and to gentamicin but not to any of the other antimicro-
bial drugs tested. 
Discussion 
A clone of hemolytic, nicotinamide-requiring E. coli 
o 18:K I :H7 that possessed type I and S fimbriae or the sfaS 
gene was isolated from the urine of 15.8% of young women 
with acute cystitis. A similar strain was recovered from stool 
samples from five of 100 healthy individuals but was not 
represented among 100 blood culture isolates of E. coli. This 
unusual clone is of special interest because of its association 
with neonatal meningitis and sepsis. Korhonen et al. [12] 
reported that E. coli 0 18:K I :H7 was the clone isolated most 
often from children with these diseases. The strains from 
these children possessed both type I and S fimbriae but did 
not produce hemolysin. A requirement for nicotinamide was 
not assessed. Both the KI capsule and S fimbriae appear to 
be important virulence factors in E. coli neonatal bacteremia 
and meningitis [12, 24, 25] . S fimbriae bind to the vascular 
endothelium of the brain and to the epithelial lining of the 
choroid plexuses and brain ventricles [26, 27]. The frequent 
association of this clone with neonatal meningitis raises the 
possibility that children of mothers who carry this strain in 
their urine or stool may be at increased risk of meningi-
tis [24]. 
We were surprised to find that only two of the 16 urinary 
isolates of E. coli 0 18:K I :H7 expressed S fimbriae on their 
surface, but all contained the sfaS gene. It is possible that S 
fimbriae undergo phase variation and that the relevant ge-
netic information was not transcribed under the conditions 
in which the strains were isolated and grown. Phase variation 
is well described for type I fimbriae [28] and may be impor-
tant for S fimbriae as well. 
We confirmed the observations of 10hnson et al. [16] that 
cockatiel and pigeon egg white blocks hemagglutination by 
P-fimbriated E. coli. This method provides a relatively inex-
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pensive means of detecting man nose-resistant, non-P-fim-
briated strains. Bovine mucin is also helpful for the preli-
minary identification of mannose-resistant S-fimbriated 
strains [23]. 
We were somewhat surprised to isolate a relatively large 
number of strains of E. coli 018 from women with acute 
cystitis. The most common 0 serogroups of E. coli in outpa-
tients with urinary tract infection are I, 2,4, 6, 7, 25, 50, and 
75 [29-33]. Group 018, although less common, is repre-
sented in several large collections of isolates from the urinary 
tract [3, 32, 33]. E. coli 018 accounted for 18 (3.3%) of 539 
blood culture isolates in one study in Denmark [34]. Nine of 
these strains (I. 7% of the total) were of serogroup 0 18:H7. 
Thus it is not surprising that we did not find this serogroup 
among blood culture isolates. 
Nicotinamide-requiring strains of E. coli are the most com-
mon auxotrophs in humans [1-3]. In a survey of naturally 
occurring auxotrophic mutants of E. coli, Robeson et al. [I] 
found that 9% of 548 strains were auxotrophs. Of these, 77% 
were niacin-requiring strains isolated mostly from patients 
with urinary tract infections. In view of the relative abun-
dance of nicotinamide-requiring strains of E. coli in urinary 
tract infections, urine would be expected to contain sub-
stances supporting their growth. Microbiologically active nic-
otinic acid and nicotinamide are present in human urine 
[35]. One of the major urinary metabolites is of nicotinamide 
NI methylnicotinamide. Trigonelline is also found in urine; 
its presence may be related to smoking and to intake of cof-
fee and legumes. All of these compounds as well as quino-
Iinic acid (a precursor of nicotinic acid) supported the growth 
of the nicotinamide-requiring strains in our study. 
Achtman et al. [3] described three nicotinamide-requiring 
clones of E. coli. One of these was a hemolysin-producing 
o 18:K I strain (membrane pattern 6) isolated from patients 
with neonatal meningitis, urinary tract infection, or sepsis. A 
second clone of018:KI (membrane pattern 9) was nonhe-
molytic and was not associated with these diseases. A third 
clone was of the 0 I : K I serogroup (membrane pattern 9); 
this nonhemolytic clone was isolated from patients with uri-
nary tract infections and from patients with neonatal menin-
gitis as well as from the feces of healthy individuals. The 
authors noted that "the apparent association of hemolysin 
production or nicotinamide-requirement with disease may 
reflect the existence of a limited number of bacterial clones 
among disease isolates and the coincidental expression of 
certain properties by these clones." 
Although most of the isolates of E. coli 0 18:K I :H7 de-
scribed in this study were from the urine of young women 
with acute cystitis, the reservoir for such strains is more likely 
to be in the stool. Since these strains can cause urinary tract 
infections and can be obtained in relatively pure culture 
from the urine, it is reasonable to assume that they can be 
isolated more readily from patients with urinary tract infec-
tions than from the mixed flora of the stool. More detailed 
studies are needed to determine the endemicity of this clone 
in human populations. 
It may be possible to use several inexpensive and readily 
available methods to screen for strains of E. coli that have the 
potential to produce neonatal meningitis and sepsis. These 
methods include assessment of the requirement for nicotin-
amide for growth in minimal medium; detection of man-
nose-resistant, non-P fimbriae with pigeon or cockatiel egg 
white [16]; and assay for agglutination of bovine erythro-
cytes. The ultimate value of these markers as epidemiologi-
cal tools needs to be determined. 
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